Ep. 154: DICE Therapeutics CEO Kevin Judice, Brunswick, Chegg

from The Drill Down · host Cory Johnson

DICE Therapeutics CEO Kevin Judice, PhD., (DICE), explains the company’s focus on democratizing skin disease therapies. Brunswick (BC) says the business is doing well… but is anyone listening? Chegg (CHGG) sounds the alarm about the current state of higher education in the U.S. The Drill Down with Cory Johnson offers a regular look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published May 4, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 154: DICE Therapeutics CEO Kevin Judice, Brunswick, Chegg

0:00 44:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Drill Down?

This episode is 44 minutes long.

When was this The Drill Down episode published?

This episode was published on May 4, 2022.

Can I download this The Drill Down episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!